Global OTC Drug Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01251235

Publication Date:

January 27, 2025

Pages:

136

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global OTC Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淥TC Drug Industry Forecast鈥� looks at past sales and reviews total world OTC Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected OTC Drug sales for 2025 through 2031. With OTC Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Drug industry.
This Insight Report provides a comprehensive analysis of the global OTC Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on OTC Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global OTC Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
Class A OTC Drug
Class B OTC Drug
Segmentation by Application:
Hospital
Clinic
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Drug Market Size (2020-2031)
2.1.2 OTC Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for OTC Drug by Country/Region (2020, 2024 & 2031)
2.2 OTC Drug Segment by Type
2.2.1 Class A OTC Drug
2.2.2 Class B OTC Drug
2.3 OTC Drug Market Size by Type
2.3.1 OTC Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global OTC Drug Market Size Market Share by Type (2020-2025)
2.4 OTC Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.5 OTC Drug Market Size by Application
2.5.1 OTC Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global OTC Drug Market Size Market Share by Application (2020-2025)
3 OTC Drug Market Size by Player
3.1 OTC Drug Market Size Market Share by Player
3.1.1 Global OTC Drug Revenue by Player (2020-2025)
3.1.2 Global OTC Drug Revenue Market Share by Player (2020-2025)
3.2 Global OTC Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Drug by Region
4.1 OTC Drug Market Size by Region (2020-2025)
4.2 Global OTC Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas OTC Drug Market Size Growth (2020-2025)
4.4 APAC OTC Drug Market Size Growth (2020-2025)
4.5 Europe OTC Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa OTC Drug Market Size Growth (2020-2025)
5 Americas
5.1 Americas OTC Drug Market Size by Country (2020-2025)
5.2 Americas OTC Drug Market Size by Type (2020-2025)
5.3 Americas OTC Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Drug Market Size by Region (2020-2025)
6.2 APAC OTC Drug Market Size by Type (2020-2025)
6.3 APAC OTC Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Drug Market Size by Country (2020-2025)
7.2 Europe OTC Drug Market Size by Type (2020-2025)
7.3 Europe OTC Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Drug by Region (2020-2025)
8.2 Middle East & Africa OTC Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa OTC Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Drug Market Forecast
10.1 Global OTC Drug Forecast by Region (2026-2031)
10.1.1 Global OTC Drug Forecast by Region (2026-2031)
10.1.2 Americas OTC Drug Forecast
10.1.3 APAC OTC Drug Forecast
10.1.4 Europe OTC Drug Forecast
10.1.5 Middle East & Africa OTC Drug Forecast
10.2 Americas OTC Drug Forecast by Country (2026-2031)
10.2.1 United States Market OTC Drug Forecast
10.2.2 Canada Market OTC Drug Forecast
10.2.3 Mexico Market OTC Drug Forecast
10.2.4 Brazil Market OTC Drug Forecast
10.3 APAC OTC Drug Forecast by Region (2026-2031)
10.3.1 China OTC Drug Market Forecast
10.3.2 Japan Market OTC Drug Forecast
10.3.3 Korea Market OTC Drug Forecast
10.3.4 Southeast Asia Market OTC Drug Forecast
10.3.5 India Market OTC Drug Forecast
10.3.6 Australia Market OTC Drug Forecast
10.4 Europe OTC Drug Forecast by Country (2026-2031)
10.4.1 Germany Market OTC Drug Forecast
10.4.2 France Market OTC Drug Forecast
10.4.3 UK Market OTC Drug Forecast
10.4.4 Italy Market OTC Drug Forecast
10.4.5 Russia Market OTC Drug Forecast
10.5 Middle East & Africa OTC Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market OTC Drug Forecast
10.5.2 South Africa Market OTC Drug Forecast
10.5.3 Israel Market OTC Drug Forecast
10.5.4 Turkey Market OTC Drug Forecast
10.6 Global OTC Drug Forecast by Type (2026-2031)
10.7 Global OTC Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market OTC Drug Forecast
11 Key Players Analysis
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Information
11.1.2 Bayer HealthCare OTC Drug Product Offered
11.1.3 Bayer HealthCare OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bayer HealthCare Main Business Overview
11.1.5 Bayer HealthCare Latest Developments
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Information
11.2.2 GlaxoSmithKline(GSK) OTC Drug Product Offered
11.2.3 GlaxoSmithKline(GSK) OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 GlaxoSmithKline(GSK) Main Business Overview
11.2.5 GlaxoSmithKline(GSK) Latest Developments
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Information
11.3.2 Johnson&Johnson OTC Drug Product Offered
11.3.3 Johnson&Johnson OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Johnson&Johnson Main Business Overview
11.3.5 Johnson&Johnson Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer OTC Drug Product Offered
11.4.3 Pfizer OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi OTC Drug Product Offered
11.5.3 Sanofi OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca OTC Drug Product Offered
11.6.3 AstraZeneca OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 BioGaia
11.7.1 BioGaia Company Information
11.7.2 BioGaia OTC Drug Product Offered
11.7.3 BioGaia OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 BioGaia Main Business Overview
11.7.5 BioGaia Latest Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Information
11.8.2 Bristol Myers Squibb OTC Drug Product Offered
11.8.3 Bristol Myers Squibb OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bristol Myers Squibb Main Business Overview
11.8.5 Bristol Myers Squibb Latest Developments
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Information
11.9.2 Bukwang Pharmaceutica OTC Drug Product Offered
11.9.3 Bukwang Pharmaceutica OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bukwang Pharmaceutica Main Business Overview
11.9.5 Bukwang Pharmaceutica Latest Developments
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Information
11.10.2 Chr. Hansen OTC Drug Product Offered
11.10.3 Chr. Hansen OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Chr. Hansen Main Business Overview
11.10.5 Chr. Hansen Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla OTC Drug Product Offered
11.11.3 Cipla OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 CoLucid
11.12.1 CoLucid Company Information
11.12.2 CoLucid OTC Drug Product Offered
11.12.3 CoLucid OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 CoLucid Main Business Overview
11.12.5 CoLucid Latest Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Information
11.13.2 Daiichi Sankyo OTC Drug Product Offered
11.13.3 Daiichi Sankyo OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Daiichi Sankyo Main Business Overview
11.13.5 Daiichi Sankyo Latest Developments
11.14 Friggs
11.14.1 Friggs Company Information
11.14.2 Friggs OTC Drug Product Offered
11.14.3 Friggs OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Friggs Main Business Overview
11.14.5 Friggs Latest Developments
11.15 DSM
11.15.1 DSM Company Information
11.15.2 DSM OTC Drug Product Offered
11.15.3 DSM OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 DSM Main Business Overview
11.15.5 DSM Latest Developments
11.16 Eisai
11.16.1 Eisai Company Information
11.16.2 Eisai OTC Drug Product Offered
11.16.3 Eisai OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Eisai Main Business Overview
11.16.5 Eisai Latest Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Information
11.17.2 Eli Lilly OTC Drug Product Offered
11.17.3 Eli Lilly OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Eli Lilly Main Business Overview
11.17.5 Eli Lilly Latest Developments
11.18 Herbalife
11.18.1 Herbalife Company Information
11.18.2 Herbalife OTC Drug Product Offered
11.18.3 Herbalife OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Herbalife Main Business Overview
11.18.5 Herbalife Latest Developments
11.19 Euradite
11.19.1 Euradite Company Information
11.19.2 Euradite OTC Drug Product Offered
11.19.3 Euradite OTC Drug Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Euradite Main Business Overview
11.19.5 Euradite Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂